Caribou Biosciences Inc

CRBUStocksBiotechnologyUnited StatesNasdaqUSD

Price

$1.13

Today

-4.6%

YTD

-27.6%

About

Caribou Biosciences, Inc. is a clinical-stage biopharmaceutical company using CRISPR gene-editing technology to transform cell therapies. It functions primarily in the US, dedicating its resources to making a significant impact in the lives of patients in need of new therapeutic solutions. Positioned in the ever-evolving biotechnology industry, Caribou Biosciences has a commitment to discovering and developing novel CRISPR-Cas gene-edited cell therapies. The company operates independently with significant partnerships with AbbVie and equity investment from Pfizer. Track the share price of CRBU by adding it to your eToro watchlist.

Price chart

Closing price history for CRBU (1D candles).

Open positions

Current open positions for this instrument from your live portfolio.

Open positions

Unrealized return

+0.0%

No open positions exist for this instrument at the moment.

Financial insights

Valuation

P/E (TTM)-1.10

P/S (TTM)11.98

P/B (TTM)1.29

Market cap$127.58M

Cap tierMicro-cap

Industry avg P/E-1.91

Profitability

Gross margin74.22%

EBIT margin-1090.90%

Net margin-1619.88%

ROE-78.27%

ROA-56.87%

Earnings & Revenue

Revenue (TTM)$10.04M

Revenue growth (1Y)+10.0%

EPS (TTM)-$1.08

Free cash flow$-95.75M

Total debt$26.66M

Dividends & Risk

Dividend rate$0.00

Dividend yield0.00%

Beta (5Y)1.90

Employees97

Next earnings11 Nov '26

Trade history

Closed trades

Realized return

+0.0%

No stored closed trades exist for this instrument yet.